Study Report

Basic Info
| Reference |
Halmai Z, 2013 PMID: 23602648
|
| Citation |
Halmai, Z., P. Dome, et al. (2013). "Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms." J Affect Disord.
|
| Disease Type |
bipolar disorder & MDD |
| Study Design |
case-control |
| Study Type |
Candidate-gene association study |
| Sample Size |
195 MDD patients, 79 BPD-I patients, 41 BPD-II patients and 373 controls |
| SNP/Region/Marker Size |
2 SNPs |
| Predominant Ethnicity |
|
| Population |
Hungarian |
| Gender |
74.4% female MDD cases, 76.7% female BD cases, 70% female controls |
| Age Group |
adults
:
MDD cases: average age 48.6 (S.D.11.8) years, BPD cases: average age 45.2 (S.D. 10.7) years; mean age: 28.3 (S.D.12.4) years of controls
|

Detail Info
| Sample Diagnosis |
DSM-IV |
| Sample Status |
In this study, 315 inpatients with a current major depressive episode were recruited at the Department of Psychiatry, Kutvolgyi Clinical Centre. The depression severity was assessed with MADRS at the recruitment. |
| Technique |
The rs2230912 was genotyped using pre-designed TaqMan kit on 7300 Real-Time PCR System. The rs1653625 was genotyped by Eco24I restriction digestion method described earlier. |
| Statistical Method |
Chi-square analysis was carried out in the case-control setup. Genetic association analyses within the patient and control samples were carried out by analyses of covariance (ANCOVA or MANCOVA) using the symptom severity scale(s) as the dependent variable(s) and the P2RX7 genotypes as the grouping variable. |
| Result Summary |
In the case-control analysis we did not find any significant differences between genotype frequencies of either BPD or MDD cases and controls. However, BPD patients carrying at least one rs2230912G-allele scored higher on both MADRS and HADS-depression scale (nominal p-value was 0.028 and 0.003, respectively). The rs1653625AA genotype was also associated with higher depression scores in the BPD group (nominal p-value of MADRS: 0.019, HADS-depression: 0.017). After correction for multiple testing, the association between rs2230912 and HADS-depression score remained significant in the BPD group (p<0.006); this genetic effect explained 9% of the variance (partial eta2=0.09). In the MDD group we did not find any significant genetic effect. The relatively small number of BPD patients warrants for a replication study. Our genetic association study supports the association between P2RX7 gene and severity of depressive symptoms in BPD patients. |

Genetic factors reported by this study for BD

Genetic factors reported by this study for SZ and/or MDD